as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.88%
Downside
2.99%
Upside
52 Week's Low
52 Week's High
55.46%
Downside
43.38%
Upside
Check Arcturus Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$491.2M
EPS (TTM)
-2.5294
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7.83
Industry PE ratio
-3.9281873111782475
P/B Ratio
0PEG Ratio
0EBITDA
-69.3M
Revenue (TTM)
122.1M
Profit Margin
-49.27%
Return On Equity TTM
0.00%
Track how Arcturus Therapeutics Holdings Inc P/E has moved over time to understand its valuation trends.
Arcturus Therapeutics Holdings Inc in the last 5 years
Lowest (4.32x)
March 31, 2023
Today (-7.83x)
September 17, 2025
Industry (-3.93x)
September 17, 2025
Highest (51.28x)
December 31, 2022
Today’s Price to Earnings Ratio: -7.83x
Compare market cap, revenue, PE, and other key metrics of Arcturus Therapeutics Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $491.2M | -60.18% | -7.83 | -49.27% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Arcturus Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arcturus Therapeutics Holdings Inc investment value today
Current value as on today
₹90,510
Returns
Returns from Arcturus Therapeutics Holdings Inc Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 16 analysts
87.50%
Buy
6.25%
Hold
6.25%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Arcturus Therapeutics Holdings Inc. Average target price of $68.9
Get share price movements and forecasts by analysts on Arcturus Therapeutics Holdings Inc.
What analysts predicted
73.8%UPSIDE
Target Price
$68.9
Current Price
$18.05
Analyzed by
16 Analysts
Target
$68.90
Arcturus Therapeutics Holdings Inc target price $68.9, a slight upside of 73.8% compared to current price of $18.05. According to 16 analysts rating.
Search interest for Arcturus Therapeutics Holdings Inc Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, -30.00M → -9.18M (in $), with an average increase of 83.3% per quarter
Price Rise
In the last 3 months, ARCT stock has moved up by 47.3%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 82.0%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 100.3%
Revenue Fall
Revenue is down for the last 2 quarters, 29.38M → 28.30M (in $), with an average decrease of 3.7% per quarter
Organisation | Arcturus Therapeutics Holdings Inc |
Headquarters | 10628 Science Center Drive, San Diego, CA, United States, 92121 |
Industry | Health Technology |
CEO | Mr. Joseph E. Payne M.Sc. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Joseph E. Payne M.Sc. | Founder, President, CEO & Director |
Dr. Igor Smolenov M.D., Ph.D. | Chief Development Officer |
Dr. Juergen Froehlich FCPh, M.D., MBA | Chief Medical Officer |
Ms. Roberta Duncan | Chief Strategy Officer |
Dr. Padmanabh Chivukula Ph.D. | Founder, Chief Scientific Officer, COO & Secretary |
Mr. Andrew H. Sassine MBA | CFO & Director |
Mr. Lance Kurata | Chief Legal Officer |
Ms. Neda Safarzadeh | Vice President and Head of IR/PR & Marketing |
Ms. Natasha O. Bowman | Chief Human Resources Officer |
Mr. Kevin T. Skol | Chief Business Officer |
Arcturus Therapeutics Holdings Inc share price today is $18.05 as on at the close of the market. Arcturus Therapeutics Holdings Inc share today touched a day high of $18.59 and a low of $17.71.
Arcturus Therapeutics Holdings Inc share touched a 52 week high of $25.88 on and a 52 week low of $8.04 on . Arcturus Therapeutics Holdings Inc stock price today i.e. is closed at $18.05,which is 30.26% down from its 52 week high and 124.50% up from its 52 week low.
Arcturus Therapeutics Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Arcturus Therapeutics Holdings Inc (ARCT) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Arcturus Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcturus Therapeutics Holdings Inc share’s latest price of $18.05 as on September 18, 2025 at 1:29 am IST, you will get 0.5540 shares of Arcturus Therapeutics Holdings Inc. Learn more about
fractional shares .
Arcturus Therapeutics Holdings Inc stock has given -60.18% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?